Affiliation:
1. University of New Mexico, School of Medicine, Albuquerque, New Mexico
Abstract
Obesity is a well-documented risk factor of complications and poor patient outcomes after orthopaedic surgery. Glucagon-like peptide-1 (GLP-1) receptor agonists can be an effective way to achieve patients’ weight loss goals that are more facile than previously used weight loss avenues. Other weight loss medications and bariatric surgery have significant side effects and complications. GLP-1 has decreased cardiac morbidity and mortality, profoundly affects weight loss, and allows for better glucose control in patients with diabetes. GLP-1 should be temporarily discontinued one dose before general anesthesia due to slowed gastric emptying.
Publisher
Ovid Technologies (Wolters Kluwer Health)